University of Central Florida

Submit a New Inquiry

Technology #2021-065 - Chaperonin-Containing TCP-1 Inhibitors for the Treatment of Cancer

University of Central Florida contracts with Nouvant to provide this service.

Your inquiry will be sent to this technology's managers. All fields are required unless otherwise noted.

Optional

Optional

By submitting this inquiry you accept the terms of the Privacy Policy and Terms of Service.

Powered by Nouvant